[Darbepoetin alfa (Aranesp) as supportive therapy in patients with germ cell tumors].
Rexer
H
H
MeckEvidence, Geschäftsstelle der AUO, Seestr. 11, 17252, Schwarz. AUO@MeckEvidence.de
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000209:etiology / Q000517:prevention & control*; D017024:Chemotherapy, Adjuvant / Q000379:methods; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006397:Hematinics / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D006397:Hematinics; D004921:Erythropoietin; D000068256:Darbepoetin alfa